James Garner

James Garner

Company: Kazia Therapeutics

Job title: Chief Executive Officer


Paxalisib In Glioblastoma – Key Learnings From A Phase II Study in Newly-Diagnosed Patients 3:30 pm

Study design and rationale Efficacy and safety outcomes Directions for future researchRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.